Z6尊龙
Other Affiliated Sites
Techdow Pharma China
Techdow Pharma UK
Techdow Pharma Poland
Techdow Pharma Italy
Techdow Pharma Spain
Techdow Pharma Germany
Techdow Pharma US
Cytovance Biologics
SPL
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2021.05.20
Z6尊龙果真刊行公司债券2021年跟踪评级报告
2021.05.19
关于孙暄先生增持公司H股妄想的希望通告
2021.05.07
关于董事告退及妄想增持公司H股的通告
2021.04.29
深圳市高新投集团有限公司2020年年度财务报表(未经审计)
2021.04.28
关于控股子公司品种临床试验申请获得受理的通告
2021.04.23
关于2020年年度股东大会增添暂时提案暨股东大会增补通知的通告
2021.04.23
H股通告
2021.04.20
关于董事告退及选举非自力董事的通告
2021.04.20
第五届董事会第八次聚会决议通告
2021.04.14
H股通告
第一页
上一页
17
18
19
20
21
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright ? 2024 Hepalink Group. All Rights Reserved.
【网站地图】
【sitemap】